Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 4
1952 1
1954 2
1955 3
1956 1
1957 1
1959 3
1961 2
1962 2
1964 2
1965 1
1966 3
1968 2
1969 3
1970 3
1971 5
1972 3
1973 7
1974 4
1975 6
1976 3
1977 6
1978 7
1979 11
1980 7
1981 13
1982 13
1983 12
1984 12
1985 12
1986 18
1987 26
1988 15
1989 14
1990 16
1991 18
1992 14
1993 14
1994 18
1995 22
1996 20
1997 27
1998 21
1999 16
2000 24
2001 22
2002 16
2003 23
2004 25
2005 34
2006 33
2007 14
2008 27
2009 27
2010 38
2011 28
2012 36
2013 47
2014 41
2015 39
2016 29
2017 40
2018 39
2019 33
2020 29
2021 35
2022 44
2023 50
2024 35
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,130 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. Among authors: nagao s. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
[Ⅳ.Endometrial Cancer].
Nagao S. Nagao S. Gan To Kagaku Ryoho. 2020 Feb;47(2):247-251. Gan To Kagaku Ryoho. 2020. PMID: 32381957 Japanese. No abstract available.
Intraperitoneal Carboplatin for Ovarian Cancer - A Phase 2/3 Trial.
Nagao S, Fujiwara K, Yamamoto K, Tanabe H, Okamoto A, Takehara K, Saito M, Fujiwara H, Tan DSP, Yamaguchi S, Adachi S, Kikuchi A, Hirasawa T, Yokoi T, Nagai T, Sato T, Kamiura S, Fujishita A, Loong WW, Chan K, Syks P, Olawaye A, Ryu SY, Shigeta H, Kondo E, Yokoyama Y, Matsumoto T, Hasegawa K, Enomoto T. Nagao S, et al. NEJM Evid. 2023 May;2(5):EVIDoa2200225. doi: 10.1056/EVIDoa2200225. Epub 2023 Apr 21. NEJM Evid. 2023. PMID: 38320049 Clinical Trial.
Parietal lipomeningocele--case report.
Yamashita S, Kunishio K, Tamiya T, Nakamura T, Ogawa D, Igawa HH, Kuroda Y, Nagao S. Yamashita S, et al. Among authors: nagao s. Neurol Med Chir (Tokyo). 2005 Feb;45(2):112-5. doi: 10.2176/nmc.45.112. Neurol Med Chir (Tokyo). 2005. PMID: 15722612 Free article. Review.
Neuropathological comorbidity associated with argyrophilic grain disease.
Yokota O, Miki T, Ikeda C, Nagao S, Takenoshita S, Ishizu H, Haraguchi T, Kuroda S, Terada S, Yamada N. Yokota O, et al. Among authors: nagao s. Neuropathology. 2018 Feb;38(1):82-97. doi: 10.1111/neup.12429. Epub 2017 Sep 14. Neuropathology. 2018. PMID: 28906054 Review.
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.
Itamochi H, Takeshima N, Hamanishi J, Hasegawa K, Matsuura M, Miura K, Nagao S, Nakai H, Tanaka N, Tokunaga H, Nishio S, Watari H, Yokoyama Y, Kase Y, Sumino S, Kato A, Suri A, Yasuoka T, Takehara K. Itamochi H, et al. Among authors: nagao s. J Gynecol Oncol. 2024 Sep;35(5):e115. doi: 10.3802/jgo.2024.35.e115. Epub 2024 Jul 17. J Gynecol Oncol. 2024. PMID: 39058367 Free PMC article. Clinical Trial.
1,130 results